BRPI0513856A - uso de um composto peptìdico - Google Patents
uso de um composto peptìdicoInfo
- Publication number
- BRPI0513856A BRPI0513856A BRPI0513856-6A BRPI0513856A BRPI0513856A BR PI0513856 A BRPI0513856 A BR PI0513856A BR PI0513856 A BRPI0513856 A BR PI0513856A BR PI0513856 A BRPI0513856 A BR PI0513856A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- peptide compound
- toxins
- peptide
- bacterial
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 231100000699 Bacterial toxin Toxicity 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000000688 bacterial toxin Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 abstract 1
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04077175A EP1621205A1 (en) | 2004-07-28 | 2004-07-28 | Antimicrobial peptides derived from CAP18 |
| PCT/NL2005/000545 WO2006011792A2 (en) | 2004-07-28 | 2005-07-26 | Antimicrobial peptides derived from cap18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0513856A true BRPI0513856A (pt) | 2008-05-20 |
Family
ID=34928414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0513856-6A BRPI0513856A (pt) | 2004-07-28 | 2005-07-26 | uso de um composto peptìdico |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7803756B2 (https=) |
| EP (3) | EP1621205A1 (https=) |
| JP (1) | JP2008508265A (https=) |
| KR (1) | KR20070050941A (https=) |
| CN (1) | CN101018563A (https=) |
| AU (1) | AU2005267651B2 (https=) |
| BR (1) | BRPI0513856A (https=) |
| CA (1) | CA2574959A1 (https=) |
| NZ (1) | NZ553175A (https=) |
| RU (1) | RU2392962C2 (https=) |
| WO (1) | WO2006011792A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1621205A1 (en) * | 2004-07-28 | 2006-02-01 | OctoPlus Technologies B.V. | Antimicrobial peptides derived from CAP18 |
| JP5762683B2 (ja) | 2006-12-01 | 2015-08-12 | ラクレード，インコーポレーテッド | 耳内のバイオフィルムを溶解するための加水分解酵素及び酸化酵素の使用 |
| EP2175865A4 (en) | 2007-07-25 | 2012-01-11 | Biolex Therapeutics Inc | INTERFERON DRUG PRODUCTS WITH CONTROLLED RELEASE AND TREATMENT OF HCV INFECTIONS THEREWITH |
| US20110039763A1 (en) | 2009-01-06 | 2011-02-17 | C3 Jian, Inc. | Targeted antimicrobial moieties |
| US20130079382A1 (en) | 2009-10-12 | 2013-03-28 | Larry J. Smith | Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro |
| RU2434880C1 (ru) * | 2010-07-21 | 2011-11-27 | Общество С Ограниченной Ответственностью "Биохарт" | Полипептид, имеющий антибактериальную активность и пригодный для получения лекарственных средств для лечения бактериальных инфекций человека |
| BR112014027818B1 (pt) * | 2012-05-09 | 2023-03-28 | Contrafect Corporation | Usos de composições compreendendo polipeptídeo de lisina para prevenção, ruptura ou tratamento de um biofilme bacteriano |
| CN105555290B (zh) * | 2013-05-10 | 2021-11-09 | 莱顿大学学术医院以Lumc的名义运作 | 抗微生物肽 |
| US9387189B2 (en) | 2013-05-22 | 2016-07-12 | Professional Compounding Centers Of America (Pcca) | Antibiotic composition comprising a chemotactic agent and a nutrient dispersion |
| WO2015075406A1 (en) * | 2013-11-19 | 2015-05-28 | Lipopeptide Ab | New treatment of chronic ulcers |
| PL3087092T3 (pl) | 2013-12-12 | 2018-12-31 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Peptyd przeciwdrobnoustrojowy i jego zastosowania |
| WO2015164289A1 (en) * | 2014-04-21 | 2015-10-29 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of fungal infections |
| US20250034218A1 (en) * | 2021-09-21 | 2025-01-30 | Biomedit, Llc | Antimicrobial peptides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4037525B2 (ja) * | 1998-03-25 | 2008-01-23 | 生化学工業株式会社 | 新規抗菌性ペプチド |
| ATE435870T1 (de) * | 2003-01-28 | 2009-07-15 | Academisch Ziekenhuis Leiden | Aus ll-37 abgeleiteten peptidinhibitoren von toxinen |
| WO2005040192A2 (en) * | 2003-10-21 | 2005-05-06 | The Regents Of The University Of California | Human cathelicidin antimicrobial peptides |
| EP1621205A1 (en) * | 2004-07-28 | 2006-02-01 | OctoPlus Technologies B.V. | Antimicrobial peptides derived from CAP18 |
-
2004
- 2004-07-28 EP EP04077175A patent/EP1621205A1/en not_active Withdrawn
-
2005
- 2005-07-26 NZ NZ553175A patent/NZ553175A/en unknown
- 2005-07-26 EP EP09158381A patent/EP2221061A1/en not_active Withdrawn
- 2005-07-26 EP EP05769152A patent/EP1784206A2/en not_active Withdrawn
- 2005-07-26 RU RU2007107390/15A patent/RU2392962C2/ru not_active IP Right Cessation
- 2005-07-26 KR KR1020077004988A patent/KR20070050941A/ko not_active Withdrawn
- 2005-07-26 AU AU2005267651A patent/AU2005267651B2/en not_active Ceased
- 2005-07-26 CN CNA2005800255122A patent/CN101018563A/zh active Pending
- 2005-07-26 JP JP2007523501A patent/JP2008508265A/ja active Pending
- 2005-07-26 US US11/658,415 patent/US7803756B2/en not_active Expired - Fee Related
- 2005-07-26 BR BRPI0513856-6A patent/BRPI0513856A/pt not_active IP Right Cessation
- 2005-07-26 CA CA002574959A patent/CA2574959A1/en not_active Abandoned
- 2005-07-26 WO PCT/NL2005/000545 patent/WO2006011792A2/en not_active Ceased
-
2010
- 2010-09-14 US US12/882,089 patent/US20110053835A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006011792A3 (en) | 2006-09-14 |
| KR20070050941A (ko) | 2007-05-16 |
| CA2574959A1 (en) | 2006-02-02 |
| EP1621205A1 (en) | 2006-02-01 |
| WO2006011792A2 (en) | 2006-02-02 |
| AU2005267651B2 (en) | 2010-05-27 |
| JP2008508265A (ja) | 2008-03-21 |
| EP1784206A2 (en) | 2007-05-16 |
| RU2392962C2 (ru) | 2010-06-27 |
| EP2221061A1 (en) | 2010-08-25 |
| US20110053835A1 (en) | 2011-03-03 |
| US7803756B2 (en) | 2010-09-28 |
| NZ553175A (en) | 2009-10-30 |
| AU2005267651A1 (en) | 2006-02-02 |
| US20080249022A1 (en) | 2008-10-09 |
| RU2007107390A (ru) | 2008-09-10 |
| CN101018563A (zh) | 2007-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0513856A (pt) | uso de um composto peptìdico | |
| BRPI0510428A (pt) | composições tópicas de metadona e processos para utilização das mesmas | |
| BRPI0810064B8 (pt) | compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos | |
| BRPI0414581C1 (pt) | composto, composição farmacêutica compreendendo o referido composto e uso do referido composto | |
| MY150958A (en) | Compounds for the treatment of multi-drug resistant bacterial infections | |
| BRPI0411016A (pt) | composições antisépticas, processos e sistemas | |
| BR0317564A (pt) | Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos | |
| BRPI0821110B8 (pt) | anticorpo de neutralização de anti-nr10/il31ra, composição farmacêutica compreendendo o referido anticorpo e uso do mesmo | |
| BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0418099A (pt) | compostos, composição farmacêutica, e uso de um composto | |
| NZ597046A (en) | Use of alpha-toxin for treating and preventing staphylococcus infections | |
| NO20076675L (no) | Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet | |
| EA200802166A1 (ru) | Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью | |
| CL2004000930A1 (es) | Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos. | |
| BRPI0612125A2 (pt) | compostos da fórmula (i), processo para a fabricação destes, composto da fórmula iiia, composições farmacêuticas, método para o tratamento e/ou profilaxia de doenças associadas à modulação dos receptores cb1 e uso de compostos | |
| BRPI0516077A (pt) | composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes | |
| BR0309757A (pt) | 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases | |
| UY28542A1 (es) | Amidas macrocíclicas antibacterianas | |
| BRPI0613999B8 (pt) | uso de um composto derivado de quinolina, o referido composto, sua combinação, composição farmacêutica, uso da referida combinação, e produto | |
| BRPI0514892A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
| DE60217292D1 (de) | Veterinärmedizinische dermatologische zusammensetzung | |
| BRPI0515555A (pt) | composição farmacêutica compreendendo éster de temozolomida | |
| ATE495186T1 (de) | Antibakterielle amid-makrozyklen iv | |
| BRPI0518554A2 (pt) | uso de um inibidor de pde3 | |
| AR074059A1 (es) | Tratamiento de infecciones bacterianas intracelulares |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2316 DE 26-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |